Management
BIOCRATES is lead by a highly experienced and dedicated team of experts, ready to lead Biocrates into the next growth phase.
Elgar Schnegg, MBA
Chief Executive Officer
Elgar Schnegg joined BIOCRATES in 2008 as chief executive officer. Mr Schnegg has an outstanding track record in the pharmaceutical and FMCG (fast moving consumer goods) industries. Before 2008, Mr Schnegg was managing director of Sandoz Austria (Novartis), leading a three-brand organization (Sandoz, Hexal, 1A) into the top 10 of national pharmaceutical companies. Before, Elgar Schnegg had spent several years in the FMCG industry as general manager of international business for Head AG. He started his career with Eli Lilly Inc., a leading research-based pharmaceutical company, moving through the sales and marketing ranks to eventually lead a foreign subsidiary business as managing director . Mr Schnegg, who graduated from Innsbruck University with a degree in economics and completed an MBA at the University of Dallas, Texas, also teaches MBA courses as part of the biotech program at the University of Krems, Austria.
Ralph Zahn, PhD
Chief Technology Officer
Ralph Zahn joined BIOCRATES in October 2010 as chief technology officer for the further development of the product pipeline and the affiliated technical and scientific assignments. He holds a PhD in natural science and has a wealth of experience in the field of biotech. After he graduated from biology, he worked as research associate and earned the doctors degree in 1994 at the Max-Planck-Institute for Biochemistry in Munich. At the Cambridge University he obtained a post-graduate doctor degree. He habilitated 2001 at the Institute for Molecular Biology and Biophysics at the Eidgenössischen Technischen Hochschule in Zurich. During his career, he was managing director at BioSafety GmbH and founder and CEO of allprion AG.
